Determination of the Relationship Between Nesfatin-1 Levels and Energy Intake Levels of Patients With Type 2 Diabetes, Insulin Resistance and Obesity
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 180
- 试验地点
- 1
- 主要终点
- Nefratin-1 in obesity
研究概览
简要总结
This research was planned to determine the level of nesfatin-1, known as satiety hormone, in type 2 diabetes, insulin diabetes and obesity patients and to determine whether there is a relationship between patients' energy intake levels. Additionally, it was aimed to evaluate the relationship between patients' nesfatin-1 values and serum glucose, insulin, lipid concentrations.
详细描述
Nesfatin-1 levels of patients with type 2 diabetes, insulin resistance and obesity will be measured. In addition, patients' daily food consumption will be taken and the amount of energy they receive will be calculated daily. The relationship between the level of nesfatin-1 in the blood and the energy received will be examined.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 19 Years 至 79 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Type 2 diabetes
- •Insulin resistance
- •Obesity disease
排除标准
- •Pediatric individuals
- •All patients who are hospitalized,
- •Liver disease
- •Cancer patients
- •Disease related to the gastrointestinal tract
- •Nephrological disease such as chronic kidney failure, acute kidney failure, nephrotic syndrome
- •Neurological disease
研究组 & 干预措施
Type 2 Diabetes group
In case of fasting, blood will be taken from patients for the measurement of nesfatin-1.
干预措施: Nesfatin-1 (Diagnostic Test)
Insulin resistance group
In case of fasting, blood will be taken from patients for the measurement of nesfatin-1.
干预措施: Nesfatin-1 (Diagnostic Test)
Obesity group
In case of fasting, blood will be taken from patients for the measurement of nesfatin-1.
干预措施: Nesfatin-1 (Diagnostic Test)
结局指标
主要结局
Nefratin-1 in obesity
时间窗: 1 day (Blood will be drawn from patients once)
Blood will be drawn from obesity patients after 12 hours of fasting (n=45)
Nefratin-1 in insulin resistance
时间窗: 1 day (Blood will be drawn from patients once)
Blood will be drawn from insulin resistance patients after 12 hours of fasting (n=45)
Nefratin-1 in type 2 diabetes
时间窗: 1 day (Blood will be drawn from patients once)
Blood will be drawn from type 2 diabates patients after 12 hours of fasting (n=45)
次要结局
未报告次要终点
研究者
Gülin Öztürk Özkan
Assistant Professor
Istanbul Medeniyet University